Plain-English translation of NCT07438496 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lupus Erythematosus, Systemic research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a medication called can help people with moderate to severe lupus. Lupus is a long-term disease where your immune system mistakenly attacks your own healthy tissues, causing swelling and redness in various parts of your body. The study will compare this medication to a placebo (a dummy treatment) to see if it works better at controlling lupus symptoms.
Current lupus treatments don't work well enough for everyone, and doctors need new options to help patients with moderate to severe disease. This medication was designed to target a specific part of the immune system that goes wrong in lupus, offering a new way to reduce symptoms and disease activity.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic regularly over one year while receiving either the medication or a placebo injection along with your regular lupus treatments. Doctors will monitor your lupus activity with blood tests and physical exams. If you respond well, you can choose to continue in an extension phase for up to three more years, where everyone receives the actual medication to see how long-term treatment works.
AI-generated summary from trial data · Jun 29, 2026 · Not medical advice
United States